You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Futibatinib

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

Not yet recruiting
  • Advanced Cholangiocarcinoma
  • +2 more
  • (no location specified)
Feb 3, 2023

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • Futibatinib
  • +6 more
  • (no location specified)
Jul 6, 2023

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Futibatinib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma Trial in Houston (Futibatinib, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations, NSCLC, KRAS Gene Mutation Trial in Santa Monica,

Recruiting
  • Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations
  • +2 more
  • Futibatinib and Binimetinib
  • Santa Monica, California
  • +2 more
Jun 2, 2022

Advanced and Metastatic Urothelial Cancer Trial in France, Spain, United States (futibatinib and pembrolizumab)

Recruiting
  • Advanced and Metastatic Urothelial Cancer
  • futibatinib and pembrolizumab
  • San Francisco, California
  • +17 more
Oct 25, 2022

Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Futibatinib
  • Futibatinib plus Fulvestrant
  • Phoenix, Arizona
  • +36 more
Jan 27, 2023

Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)

Active, not recruiting
  • Advanced or Metastatic Solid Tumor
  • +2 more
  • Futibatinib
  • Gilbert, Arizona
  • +60 more
Oct 20, 2022

Advanced Cholangiocarcinoma, FGFR2 Gene Rearrangements Trial in Worldwide (TAS-120, Cisplatin/Gemcitabine)

Active, not recruiting
  • Advanced Cholangiocarcinoma
  • FGFR2 Gene Rearrangements
  • Albuquerque, New Mexico
  • +100 more
Feb 1, 2023

Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Futibatinib
  • +9 more
  • Brussels, Belgium
  • +56 more
Nov 7, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Futibatinib
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer Trial in Tokyo (AB122, TAS-116, TAS-120)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • +3 more
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 5, 2022

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022